Inspections, Compliance, Enforcement, and Criminal Investigations
Ocean Group, Inc. (dba Ocean Fresh Fish & Seafood Marketing) - Close Out Letter 9/17/12
| Public Health Service Food and Drug Administration |
Los Angeles District |
VIA UNITED PARCEL SERVICE
SIGNATURE REQUIRED
September 17, 2012
Mr. Young W. Kim, CEO
Ocean Group, Inc.
DBA Ocean Fresh Fish & Seafood Marketing
1100 S. Santa Fe Ave.
Los Angeles, California 90021-1743
Dear Mr. Kim:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter (WL # 06-12 dated November 9, 2011). Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will. not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Alonza E. Cruse
District Director
Los Angeles District





Department of Health and Human Services

